Trends in the Annual Incidence of Carbapenem Resistant among Gram Negative Bacilli in a Large Teaching Hospital in Makah City, Saudi Arabia
暂无分享,去创建一个
H. Faidah | A. Momenah | A. Johargy | Wafa Almalki | Sami S. Ashgar | A. Elsawy | Hamdi M. El-Said | Wafaa M. Almalki | A. Barhameen | S. A. Qurashi
[1] B. Kakati,et al. Emergence of Carbapenem Resistant Non-Fermenting Gram-Negative Bacilli Isolated in an ICU of a Tertiary Care Hospital. , 2017, Journal of clinical and diagnostic research : JCDR.
[2] N. Ahmed,et al. Antimicrobial resistance of bacterial isolates from respiratory secretions of ventilated patients in a multi-specialty hospital , 2015, Avicenna Journal of Medicine.
[3] H. Giamarellou,et al. Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches , 2014, Expert opinion on pharmacotherapy.
[4] M. Al-agamy,et al. Antimicrobial Resistance Pattern and Their Beta-Lactamase Encoding Genes among Pseudomonas aeruginosa Strains Isolated from Cancer Patients , 2014, BioMed research international.
[5] Z. Memish,et al. The emergence of OXA-48- and NDM-1-positive Klebsiella pneumoniae in Riyadh, Saudi Arabia. , 2013, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[6] A. S. Attia,et al. Emergence of carbapenem-resistant Acinetobacter baumannii harboring the OXA-23 carbapenemase in intensive care units of Egyptian hospitals. , 2013, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[7] L. Metwally,et al. High prevalence of Klebsiella pneumoniae carbapenemase-mediated resistance in K. pneumoniae isolates from Egypt. , 2013, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.
[8] M. Falagas,et al. Antibiotic Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae: Systematic Evaluation of the Available Evidence , 2013, Antimicrobial Agents and Chemotherapy.
[9] P. Tiwari,et al. Assessment of Costs Associated with Hospital-Acquired Infections in a Private Tertiary Care Hospital in India. , 2013, Value in health regional issues.
[10] E. A. Elsayed,et al. High frequency of carbapenem-resistant Acinetobacter baumannii in patients with diabetes mellitus in Saudi Arabia. , 2013, Journal of medical microbiology.
[11] K. Kaye,et al. The carbapenem-resistant Enterobacteriaceae score: a bedside score to rule out infection with carbapenem-resistant Enterobacteriaceae among hospitalized patients. , 2013, American journal of infection control.
[12] P. Nordmann,et al. NDM-1, OXA-48 and OXA-181 carbapenemase-producing Enterobacteriaceae in Sultanate of Oman. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[13] P. Nordmann,et al. Carbapenem resistance in Enterobacteriaceae: here is the storm! , 2012, Trends in molecular medicine.
[14] D. Livermore,et al. Extended-spectrum and metallo-beta-lactamases among ceftazidime-resistant Pseudomonas aeruginosa in Riyadh, Saudi Arabia , 2012, Journal of chemotherapy.
[15] Thierry Naas,et al. Global Spread of Carbapenemase-producing Enterobacteriaceae , 2011, Emerging infectious diseases.
[16] Robert A. Bonomo,et al. Carbapenems: Past, Present, and Future , 2011, Antimicrobial Agents and Chemotherapy.
[17] M. Shorman,et al. Emergence of extensive drug-resistant Acinetobacter baumannii in North of Jordan , 2011 .
[18] P. Nordmann,et al. NDM-1-producing Klebsiella pneumoniae isolated in the Sultanate of Oman. , 2011, The Journal of antimicrobial chemotherapy.
[19] J. Patel,et al. Carbapenemases in Enterobacteriaceae: Activity, Epidemiology, and Laboratory Detection , 2009 .
[20] L. Dijkshoorn,et al. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii , 2007, Nature Reviews Microbiology.
[21] R. Bonomo,et al. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] Robert A. Bonomo,et al. Extended-Spectrum (cid:2) -Lactamases: a Clinical Update , 2005 .
[23] D. Yong,et al. Evaluation of the Hodge Test and the Imipenem-EDTA Double-Disk Synergy Test for Differentiating Metallo-β-Lactamase-Producing Isolates of Pseudomonas spp. and Acinetobacter spp , 2003, Journal of Clinical Microbiology.
[24] R. Gaynes,et al. Resistance to Imipenem Among Selected Gram-Negative Bacilli in the United States , 1992, Infection Control & Hospital Epidemiology.